Disease-Causing STAT3 Variants Can Be Discriminated by a Functional Flow Cytometry Test
Journal of Human Immunity · 01.05.2026 · 2 (CIS2026)
DOI: 10.70962/cis2026abstract.208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Human Immunity, online erschienen am 01.05.2026. Verfasst von Ana Esteve-Sole und 18 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Heterozygous STAT3 protein variants acting by dominant-negative (DN), gain-of-function (GOF), or haploinsufficiency (HI) mechanisms have been associated with different clinical/immunological phenotypes. However, the biological impact of STAT3 protein variants is complex to determine, and it generally requires vector generation, transfection, and multiple iterations for definition.
Objective
To establish a single, reliable test to functionally characterize putative disease-causing STAT3 protein variants in patient primary cells.
Methods
We recruited patients carrying previously published/validated STAT3-DN (n = 13), STAT3-GOF (n = 4), and STAT3-HI (n = 5) variants. We functionally evaluated the IL-10-mediated/STAT3-dependent inhibition of LPS-induced TNF-a production by peripheral blood mononuclear cell (PBMC) monocytes using flow cytometry to assess the biological impact of STAT3 protein variants. Optimization and threshold definition were performed by bootstrapping and k-fold cross-validation of the receiver operating characteristic (ROC)-area under the curve (AUC).
Results
The inhibition ratio of TNF-a production was significantly diminished in STAT3-DN (−3.44-fold, p < 0.0001) and STAT3-HI patient samples (−2.28-fold, p < 0.0001), while significantly augmented in STAT3-GOF patient samples (+1.47-fold, p = 0.002) when compared to healthy controls (HC, n = 16). Optimization of the combinations of IL-10 concentrations discriminated between HC from STAT3-DN (ROC-AUC = 1) and STAT3-GOF (ROC-AUC = 0.89). Further test optimization allowed discrimination of STAT3-HI variants when compared to HC (ROC-AUC = 1) and to STAT3-DN (ROC-AUC = 0.92).
Conclusion
Determination of the IL-10-mediated, STAT3-dependent TNF-α inhibition after LPS stimulation ratio in PBMC monocytes using flow cytometry is a sensitive and specific method to functionally assess and discriminate STAT3-DN, -GOF, and -HI variants. This test can be used in research and clinical laboratory settings.
Zitieren
APA
Esteve-Sole, A., Freeman, A. F., Hsu, A., Vogel, T. P., Satter, L. R. F., Bergerson, J. R., Webb, T., Pechacek, J., McDaniels, K., Cooper, M. A., Bouso, C., Oleastro, M., Denielian, S., Gonzalez-Granado, L. I., Lionakis, M. S., Holland, S. M., Fleisher, T. A., Kuehn, H., & Rosenzweig, S. (2026). Disease-Causing STAT3 Variants Can Be Discriminated by a Functional Flow Cytometry Test. Journal of Human Immunity, 2(CIS2026). https://doi.org/10.70962/cis2026abstract.208
Vancouver
Esteve-Sole A, Freeman AF, Hsu A, Vogel TP, Satter LRF, Bergerson JR, et al. Disease-Causing STAT3 Variants Can Be Discriminated by a Functional Flow Cytometry Test. Journal of Human Immunity. 2026;2(CIS2026). doi:10.70962/cis2026abstract.208
BibTeX
@article{EsteveSole2026,
author = {Esteve-Sole, Ana and Freeman, Alexandra F. and Hsu, Amy and Vogel, Tiphanie P. and Satter, Lisa R. Forbes and Bergerson, Jenna R.E. and Webb, Taura and Pechacek, Joseph and McDaniels, Kristen and Cooper, Megan A. and Bouso, Carolina and Oleastro, Matias and Denielian, Silvia and Gonzalez-Granado, Luis Ignacio and Lionakis, Michail S. and Holland, Steven M. and Fleisher, Thomas A. and Kuehn, HyeSun and Rosenzweig, Sergio},
title = {Disease-Causing STAT3 Variants Can Be Discriminated by a Functional Flow Cytometry Test},
journal = {Journal of Human Immunity},
year = {2026},
volume = {2},
number = {CIS2026},
doi = {10.70962/cis2026abstract.208}
}
EUVIMED